Akero Therapeutics, Inc.
US ˙ NasdaqGS ˙ US00973Y1082
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityAKRO / Akero Therapeutics, Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Simplex Trading, Llc ownership in AKRO / Akero Therapeutics, Inc.

On February 11, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Akero Therapeutics, Inc. (US:AKRO) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 4,565 shares of Akero Therapeutics, Inc.. The current value of the position is $0 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (AKRO) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AKRO / Akero Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F AKERO THERAPEUTICS COM 00973Y108 0 -100.00 0
2025-11-12 2025-09-30 13F AKERO THERAPEUTICS COM 00973Y108 4,565 4,565 0 0.0001
2025-08-05 2025-06-30 13F AKERO THERAPEUTICS COM 00973Y108 0 -40,853 -100.00 0 -100.00
2025-05-12 2025-03-31 13F AKERO THERAPEUTICS COM 00973Y108 40,853 17,998 78.75 2 0.0011
2025-02-11 2024-12-31 13F AKERO THERAPEUTICS COM 00973Y108 22,855 22,855 1 0.0004
2024-07-25 2024-06-30 13F AKERO THERAPEUTICS COM 00973Y108 0 -10,088 -100.00 0 0.0000
2024-04-25 2024-03-31 13F AKERO THERAPEUTICS COM 00973Y108 10,088 10,088 0 0.0001
2024-02-02 2023-12-31 13F AKERO THERAPEUTICS COM 00973Y108 0 -33,582 -100.00 0 -100.00
2023-11-01 2023-09-30 13F AKERO THERAPEUTICS COM 00973Y108 33,582 -21,419 -38.94 2 -50.00 0.0013
2023-08-04 2023-06-30 13F AKERO THERAPEUTICS COM 00973Y108 55,001 47,387 622.37 3 0.0021
2023-04-27 2023-03-31 13F AKERO THERAPEUTICS COM 00973Y108 7,614 -18,672 -71.03 0 -100.00 0.0003
2023-02-02 2022-12-31 13F AKERO THERAPEUTICS COM 00973Y108 26,286 -52,085 -66.46 1 -99.96 0.0016
2022-11-04 2022-09-30 13F AKERO THERAPEUTICS COM 00973Y108 78,371 78,268 75,988.35 2,668 0.0030
2022-08-03 2022-06-30 13F AKERO THERAPEUTICS COM 00973Y108 103 -68 -39.77 0 -100.00
2022-05-02 2022-03-31 13F AKERO THERAPEUTICS COM 00973Y108 171 -11,471 -98.53 2 -99.32 0.0000
2022-02-04 2021-12-31 13F AKERO THERAPEUTICS COM 00973Y108 11,642 0 0.00 295 0.00 0.0003
2021-10-28 2021-09-30 13F AKERO THERAPEUTICS COM 00973Y108 11,642 -500 -4.12 295 -1.99 0.0003
2021-08-12 2021-06-30 13F AKERO THERAPEUTICS COM 00973Y108 12,142 -55,921 -82.16 301 -84.75 0.0003
2021-04-26 2021-03-31 13F AKERO THERAPEUTICS COM 00973Y108 68,063 68,063 460.56 1,974 555.81 0.0035
2020-10-14 2020-09-30 13F AKERO THERAPEUTICS COM 00973Y108 0 -20 -100.00 0 -100.00 0.0000
2020-07-13 2020-06-30 13F AKERO THERAPEUTICS COM 00973Y108 20 20 0 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F AKERO THERAPEUTICS CALL Call 0 -100.00 0 n/a n/a n/a
2025-11-12 2025-09-30 13F AKERO THERAPEUTICS CALL Call 16,100 -77.29 1 -100.00 n/a n/a n/a
2025-08-05 2025-06-30 13F AKERO THERAPEUTICS CALL Call 70,900 8.91 4 50.00 n/a n/a n/a
2025-05-12 2025-03-31 13F AKERO THERAPEUTICS CALL Call 65,100 32.59 3 100.00 n/a n/a n/a
2025-02-11 2024-12-31 13F AKERO THERAPEUTICS CALL Call 49,100 49.70 1 n/a n/a n/a
2024-11-08 2024-09-30 13F AKERO THERAPEUTICS CALL Call 32,800 -22.82 1 n/a n/a n/a
2024-07-25 2024-06-30 13F AKERO THERAPEUTICS CALL Call 42,500 -34.01 1 -100.00 n/a n/a n/a
2024-04-25 2024-03-31 13F AKERO THERAPEUTICS CALL Call 64,400 -17.44 2 0.00 n/a n/a n/a
2024-02-02 2023-12-31 13F AKERO THERAPEUTICS CALL Call 78,000 142.99 2 0.00 n/a n/a n/a
2023-11-01 2023-09-30 13F AKERO THERAPEUTICS CALL Call 32,100 417.74 2 n/a n/a n/a
2023-08-04 2023-06-30 13F AKERO THERAPEUTICS CALL Call 6,200 -70.48 0 n/a n/a n/a
2023-04-27 2023-03-31 13F AKERO THERAPEUTICS CALL Call 21,000 -12.13 1 -100.00 n/a n/a n/a
2023-02-02 2022-12-31 13F AKERO THERAPEUTICS CALL Call 23,900 -18.98 1 -99.90 n/a n/a n/a
2022-11-04 2022-09-30 13F AKERO THERAPEUTICS CALL Call 29,500 5,800.00 1,004 25,000.00 n/a n/a n/a
2022-08-03 2022-06-30 13F AKERO THERAPEUTICS CALL Call 500 400.00 4 300.00 n/a n/a n/a
2022-05-02 2022-03-31 13F AKERO THERAPEUTICS CALL Call 100 -83.33 1 -91.67 n/a n/a n/a
2022-02-23 2021-12-31 13F/A AKERO THERAPEUTICS CALL Call 600 -62.50 12 -70.00 n/a n/a n/a
2022-02-04 2021-12-31 13F AKERO THERAPEUTICS CALL Call 1,600 40 n/a n/a n/a
2021-10-28 2021-09-30 13F AKERO THERAPEUTICS CALL Call 1,600 0.00 40 2.56 n/a n/a n/a
2021-08-12 2021-06-30 13F AKERO THERAPEUTICS CALL Call 1,600 5,417.24 39 -53.57 n/a n/a n/a
2021-04-26 2021-03-31 13F AKERO THERAPEUTICS CALL Call 29 -71.57 84 -68.06 n/a n/a n/a
2021-02-02 2020-12-31 13F AKERO THERAPEUTICS CALL Call 102 251.72 263 213.10 n/a n/a n/a
2020-10-14 2020-09-30 13F AKERO THERAPEUTICS CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-07-13 2020-06-30 13F AKERO THERAPEUTICS CALL Call 1 -92.31 2 -92.59 n/a n/a n/a
2020-04-29 2020-03-31 13F AKERO THERAPEUTICS CALL Call 13 27 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F AKERO THERAPEUTICS PUT Put 0 -100.00 0 n/a n/a n/a
2025-11-12 2025-09-30 13F AKERO THERAPEUTICS PUT Put 3,400 -85.09 0 -100.00 n/a n/a n/a
2025-08-05 2025-06-30 13F AKERO THERAPEUTICS PUT Put 22,800 -70.69 1 -66.67 n/a n/a n/a
2025-05-12 2025-03-31 13F AKERO THERAPEUTICS PUT Put 77,800 18.24 3 200.00 n/a n/a n/a
2025-02-11 2024-12-31 13F AKERO THERAPEUTICS PUT Put 65,800 200.46 2 n/a n/a n/a
2024-11-08 2024-09-30 13F AKERO THERAPEUTICS PUT Put 21,900 -11.69 1 n/a n/a n/a
2024-07-25 2024-06-30 13F AKERO THERAPEUTICS PUT Put 24,800 -36.57 1 n/a n/a n/a
2024-04-25 2024-03-31 13F AKERO THERAPEUTICS PUT Put 39,100 315.96 1 n/a n/a n/a
2024-02-02 2023-12-31 13F AKERO THERAPEUTICS PUT Put 9,400 -87.02 0 -100.00 n/a n/a n/a
2023-11-01 2023-09-30 13F AKERO THERAPEUTICS PUT Put 72,400 32.36 4 50.00 n/a n/a n/a
2023-08-04 2023-06-30 13F AKERO THERAPEUTICS PUT Put 54,700 259.87 3 n/a n/a n/a
2023-04-27 2023-03-31 13F AKERO THERAPEUTICS PUT Put 15,200 -67.17 1 -100.00 n/a n/a n/a
2023-02-02 2022-12-31 13F AKERO THERAPEUTICS PUT Put 46,300 -59.88 3 -99.95 n/a n/a n/a
2022-11-04 2022-09-30 13F AKERO THERAPEUTICS PUT Put 115,400 2,304.17 3,929 8,631.11 n/a n/a n/a
2022-08-03 2022-06-30 13F AKERO THERAPEUTICS PUT Put 4,800 4,700.00 45 4,400.00 n/a n/a n/a
2022-05-02 2022-03-31 13F AKERO THERAPEUTICS PUT Put 100 -50.00 1 -75.00 n/a n/a n/a
2022-02-23 2021-12-31 13F/A AKERO THERAPEUTICS PUT Put 200 -98.77 4 -99.03 n/a n/a n/a
2022-02-04 2021-12-31 13F AKERO THERAPEUTICS PUT Put 16,300 413 n/a n/a n/a
2021-10-28 2021-09-30 13F AKERO THERAPEUTICS PUT Put 16,300 0.00 413 2.23 n/a n/a n/a
2021-08-12 2021-06-30 13F AKERO THERAPEUTICS PUT Put 16,300 920.03 404 -91.28 n/a n/a n/a
2021-04-26 2021-03-31 13F AKERO THERAPEUTICS PUT Put 1,598 -90.20 4,635 1,047.28 n/a n/a n/a
2020-10-14 2020-09-30 13F AKERO THERAPEUTICS PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-07-13 2020-06-30 13F AKERO THERAPEUTICS PUT Put 2 0.00 4 0.00 n/a n/a n/a
2020-04-29 2020-03-31 13F AKERO THERAPEUTICS PUT Put 2 4 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.